Healthcare System Archives

The Authors’ Own Words: Predictors of HEDIS Treatment Initiation and Engagement among Patients with Opioid Use Disorder across Seven Health Systems

Nov 29, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Predictors of HEDIS Treatment Initiation and Engagement among Patients with Opioid Use Disorder across Seven Health Systems

Cynthia I. Campbell, PhD, MPH; Constance Weisner, DrPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Gwen T. Lapham, PhD, MPH, MSW; Brian K. Ahmedani, PhD, LMSW; Bobbi Jo H. Yarborough, PsyD; Irina V. Haller, PhD, MS; Andrea Altschuler, PhD; Rulin C. Hechter, MD, PhD; Amy M. Loree, PhD; & Andrea H. Kline-Simon, MS

Substance Abuse Vol. 40, Iss. 3, 2019

“The rates of AOD initiation and engagement for OUD patients vary widely and leave considerable room for improvement. Health systems appear to have more success at engaging younger patients in treatment, which may have positive implications for these patients long-term if they can stay engaged. The primary care and inpatient settings can present important opportunities for health systems to initiate and engage patients in treatment.”

The Authors’ Own Words: The Prevalence of HEDIS Initiation and Engagement in Treatment among Patients with Cannabis Use Disorders in Seven U.S. Health Systems

Nov 25, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The Prevalence of HEDIS Initiation and Engagement in Treatment among Patients with Cannabis Use Disorders in Seven U.S. Health Systems

Constance Weisner, DrPH, MSW; Cynthia I. Campbell, PhD, MPH; Andrea Altschuler, PhD; Bobbi Jo H. Yarborough, PsyD; Gwen T. Lapham, PhD, MPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Rulin C. Hechter, MD, PhD; Brian K. Ahmedani, PhD, LMSW; Irina V. Haller, PhD, MS; Stacy A. Sterling, DrPH, MSW; Dennis McCarty, PhD; Derek D. Satre, PhD; & Andrea H. Kline-Simon, MS

Substance Abuse Vol. 40, Iss. 3, 2019

“This observational cohort study of 15,202 patients with a cannabis use disorder (CUD) from seven U.S. healthcare systems is the first known study to describe rates of HEDIS-defined alcohol and other drug use disorder (AOD) measures for initiation and engagement in treatment among patients with a newly diagnosed CUD. For these patients, rates of initiation and engagement were low, with considerable variation across index diagnosis setting, AOD comorbidity at index diagnosis, and patient characteristics. Greater adherence to these system-level treatment measures will likely require strong leader and provider partnerships to improve recognition of and linkage to evidence-based treatment for CUD, particularly for those patients with less AOD severity who could still benefit from treatment.“

The Authors’ Own Words: ‘A Scarlet Letter:’ Stigma and Other Factors Affecting Trust in the Healthcare System for Women Seeking Substance Abuse Treatment in a Community Setting

Nov 16, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

‘A Scarlet Letter:’ Stigma and Other Factors Affecting Trust in the Healthcare System for Women Seeking Substance Abuse Treatment in a Community Setting

Joshua D. Cockroft, BA; Susie M. Adams, PhD, RN, PMHNP; Kemberlee Bonnet, MA; Deondria Matlock, MS; Jessica McMillan, DNP, RN, PMHNP; & David Schlundt , PhD

Substance Abuse Vol. 40, Iss. 2, 2019

“Though derived from a small sample size, the findings of this study demonstrate multiple factors that influence trust of the healthcare system for women who seek substance abuse treatment in a community setting. Efforts should be made to address components of healthcare organizations that predispose to stigma, poor quality of care, negatively aligned payment structure and reimbursement, ensuring patients’ rights and protections, and mediating the healthcare system’s potential role in causing or influencing an individual’s substance use disorder (SUD). These findings suggest that public health or institutional interventions to improve treatment for women with a history of SUD may require direct engagement with experiential and structural factors that influence trust and healthcare entry and engagement in order to be effective.“